Localized linear IgA disease induced by ampicillin/sulbactam

Journal of the American Academy of Dermatology

Volumn 51, Issue 1, 2004, Pages 95-98

  Shimanovich, Iakov ^a   Rose, Christian ^a   Sitaru, Cassian ^a   Bröcker, Eva B ^a   Zillikens, Detlef ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPICILLIN; ANTIBIOTIC AGENT; ANTIGEN; ANTIINFECTIVE AGENT; ATORVASTATIN; AUTOANTIBODY; AUTOANTIGEN; CRYSTAL VIOLET; GLIMEPIRIDE; IMMUNOGLOBULIN A; LOSARTAN; MOXONIDINE; OMEPRAZOLE; PHENPROCOUMON; POTASSIUM CHLORIDE; SULBACTAM; TORASEMIDE;

AGED; ANAMNESIS; ANUS; ARTICLE; BLISTER; CASE REPORT; CIRCULATION; DISEASE COURSE; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; FEVER; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; LINEAR IMMUNOGLOBULIN A DERMATOSIS; MALE; PEMPHIGOID; PNEUMONIA; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN DISEASE; SOLUBILITY; TREATMENT OUTCOME;

AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BIOPSY; DRUG ERUPTIONS; HUMANS; IMMUNOGLOBULIN A; MALE; SKIN; SKIN DISEASES, VESICULOBULLOUS; SULBACTAM;

EID: 3042737603     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.03.027     Document Type: Article

References (22)

1. Chorzelski T.P., Jablonska S. IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol. 101:1979;535-542
2. Condon C., Cotter P., Lyons J.F. Localized linear IgA disease and platelet abnormalities. Br J Dermatol. 131:1994;139-141
3. Benbenisty K.M., Bowman P.H., Davis L.S. Localized linear IgA disease responding to colchicine. Int J Dermatol. 41:2002;56-58
4. Plunkett R.W., Chiarello S.E., Beutner E.H. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol. 45:2001;691-696
5. Zillikens D., Herzele K., Georgi M., Chimanovitch I., Schumann H., Mascaro J.H. Jr., et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180. J Invest Dermatol. 113:1999;947-953
6. Kromminga A., Scheckenbach C., Georgi M., Hagel C., Arndt R., Christophers E., et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun. 15:2000;293-300
7. Person J.R., Rogers R.S. 3rd, Perry H.O. Localized pemphigoid. Br J Dermatol. 95:1976;531-534
8. Franzke C.W., Tasanen K., Schäcke H., Zhou Z., Trygvasson K., Mauch C., et al. Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 21:2002;5026-5035
9. Hirako Y., Yoshino K., Zillikens D., Owaribe K. Extracellular cleavage of bullous pemphigoid antigen 180/type XVII collagen and its involvement in hemidesmosomal assembly. J Biochem. 133:2003;197-206
10. Zone J.J., Taylor T.B., Kadunce D.P., Meyer L.J. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest. 85:1990;812-820
11. Marinkovich M.P., Taylor T.B., Keene D.R., Burgeson R.E., Zone J.J. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 106:1996;734-738
12. Pas H.H., Kloosterhuis G.J., Heeres K., van der Meer J.B., Jonkman M.F. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol. 108:1997;423-429
13. Schumann H., Baetge J., Tasanen K., Wojnarowska F., Schäcke H., Zillikens D., Bruckner-Tuderman L. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol. 156:2000;685-695
14. Wojnarowska F., Whitehead P., Leigh I.M., Bhogal B.S., Black M.M. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol. 124:1991;157-162
15. Kanitakis J., Muduit G., Cozzani E., Badinaud P., Faure M., Claudy A. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. Pediatr Dermatol. 11:1994;139-144
16. Zambruno G., Manca V., Kanitakis J., Cozzani E., Nicolas J.F., Gianetti A. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol. 31:1994;884-888
17. Paul C., Wolkenstein P., Prost C., Caux F., Rostoker G., Heller M., et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol. 136:1997;406-411
18. Wakelin S.H., Allen J., Zhou S., Wojnarowska F. Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol. 138:1998;310-314
19. Palmer R.A., Ogg G., Allen J., Banerjee A., Ryatt K.S., Ratnavel R., et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol. 145:2001;816-820
20. König C., Eickert A., Scharfetter-Kochanek K., Krieg T., Hunzelmann N. Linear IgA bullous dermatosis induced by atorvastatin. J Am Acad Dermatol. 44:2001;689-692
21. Richards S.S., Hall S., Yokel B., Whitmore S.E. A bullous eruption in an elderly woman. Arch Dermatol. 131:1995;1443-1452
22. Klein P.A., Callen J.P. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 42:2000;316-323